Articles © The authors | Journal compilation © World J Oncol and Elmer Press ™ | www.wjon.org A Review in Management of Testicular Cancer: Single Center Review

Background: Testicular cancer is one of the few solid cancers that can be cured even when it is metastasized with overall survival rate of more than 90%. The aim of this study was to establish the age adjusted incidence of testicular cancer and to critically assess the management of testicular tumor. Methods: This is a quantitative retrospective study utilizing a re-view of clinical notes for patients who underwent testicular orchi-dectomy. The number of cancer cases, types of pathology and can-cer staging were examined. Results: There is no substantial difference between the crude and the age-standardized incidence, moreover no difference from the reported crude incidence by the Scottish intercollegiate guidelines. We found 55.1 % of seminoma, 14.28 % of non-seminoma and 30.61 % of combined (seminoma and non-seminoma), and stage I disease in 61.22 % of cases, stage II in 36.73 % of cases, and stage IV in 2.04 % of cases. Most of the cancers were in the age group 20- 50 with the majority (48.97%) in the age group 31- 40. About 42.85 % of cases were identified with high tumor markers; higher percentage of seminoma at stage II (40.74%). Conclusions: There is no substantial difference between the crude and the age-standardized incidence, moreover no difference from the reported crude incidence. Most of the cancers were in the age group 20- 50 with the majority (48.97%) in the age group 31- 40. Only 25 % of seminomas had elevated tumor markers. Moreover, it is important to re-enforce strict adaptation to the IGCCCG prognos-tic factor-based classifications